Critical role of the Mac1/NOX2 pathway in mediating reactive microgliosis-generated chronic neuroinflammation and progressive neurodegeneration

Current Opinion in Pharmacology

Volumn 26, Issue , 2016, Pages 54-60

  Chen, Shih Heng ^a   Oyarzabal, Esteban A ^a,b   Hong, Jau Shyong ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN RECEPTOR; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; TOLL LIKE RECEPTOR; CD11B ANTIGEN; CYBB PROTEIN, HUMAN; MEMBRANE PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ALZHEIMER DISEASE; ARTICLE; DEGENERATIVE DISEASE; GLIOSIS; HUMAN; LIFE EXPECTANCY; MICROGLIA; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROTOXICITY; OXIDATIVE STRESS; PARKINSON DISEASE; PATTERN RECOGNITION; PRIORITY JOURNAL; PUBLIC HEALTH; ANIMAL; INFLAMMATION; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; INFLAMMATION; MACROPHAGE-1 ANTIGEN; MEMBRANE GLYCOPROTEINS; MICROGLIA; NADPH OXIDASE; NEURODEGENERATIVE DISEASES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84945143762     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2015.10.001     Document Type: Review

References (58)

1. M.L. Block, L. Zecca, and J.S. Hong Microglia-mediated neurotoxicity: uncovering the molecular mechanisms Nat Rev Neurosci 8 2007 57 69
2. H.M. Gao, and J.S. Hong Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression Trends Immunol 29 2008 357 365
3. T.C. Frank-Cannon, L.T. Alto, F.E. McAlpine, and M.G. Tansey Does neuroinflammation fan the flame in neurodegenerative diseases? Mol Neurodegener 4 2009 47
4. M.T. Heneka, M.J. Carson, J. El Khoury, G.E. Landreth, F. Brosseron, D.L. Feinstein, A.H. Jacobs, T. Wyss-Coray, J. Vitorica, R.M. Ransohoff, and et al. Neuroinflammation in Alzheimer's disease Lancet Neurol 14 2015 388 405
5. H. Kettenmann, U.K. Hanisch, M. Noda, and A. Verkhratsky Physiology of microglia Physiol Rev 91 2011 461 553
6. R. Hanamsagar, M.L. Hanke, and T. Kielian Toll-like receptor (TLR) and inflammasome actions in the central nervous system Trends Immunol 33 2012 333 342
7. D. Doens, and P.L. Fernandez Microglia receptors and their implications in the response to amyloid beta for Alzheimer's disease pathogenesis J Neuroinflammation 11 2014 48
8. D. Zhang, X. Hu, L. Qian, S.H. Chen, H. Zhou, B. Wilson, D.S. Miller, and J.S. Hong Microglial MAC1 receptor and PI3K are essential in mediating beta-amyloid peptide-induced microglial activation and subsequent neurotoxicity J Neuroinflammation 8 2011 3
9. H.M. Gao, H. Zhou, F. Zhang, B.C. Wilson, W. Kam, and J.S. Hong HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration J Neurosci 31 2011 1081 1092
10. M. Carty, and A.G. Bowie Evaluating the role of Toll-like receptors in diseases of the central nervous system Biochem Pharmacol 81 2011 825 837
11. J.G. Walsh, D.A. Muruve, and C. Power Inflammasomes in the CNS Nat Rev Neurosci 15 2014 84 97
12. S.H. Chen, E.A. Oyarzabal, Y.F. Sung, C.H. Chu, Q. Wang, S.L. Chen, R.B. Lu, and J.S. Hong Microglial regulation of immunological and neuroprotective functions of astroglia Glia 63 2015 118 131
13. P. Theriault, A. ElAli, and S. Rivest The dynamics of monocytes and microglia in Alzheimer's disease Alzheimers Res Ther 7 2015 41
14. M. Prinz, and J. Priller Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease Nat Rev Neurosci 15 2014 300 312
15. J.E. Burda, and M.V. Sofroniew Reactive gliosis and the multicellular response to CNS damage and disease Neuron 81 2014 229 248
16. M.T. Heneka, M.P. Kummer, and E. Latz Innate immune activation in neurodegenerative disease Nat Rev Immunol 14 2014 463 477
17. S. Lehnardt Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury Glia 58 2010 253 263
18. T. Kawai, and S. Akira Toll-like receptors and their crosstalk with other innate receptors in infection and immunity Immunity 34 2011 637 650
19. A.M. Piccinini, and K.S. Midwood DAMPening inflammation by modulating TLR signalling Mediators Inflamm 2010 2010
20. C. Kim, D.H. Ho, J.E. Suk, S. You, S. Michael, J. Kang, S. Joong Lee, E. Masliah, D. Hwang, H.J. Lee, and et al. Neuron-released oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia Nat Commun 4 2013 1562
21. S. Walter, M. Letiembre, Y. Liu, H. Heine, B. Penke, W. Hao, B. Bode, N. Manietta, J. Walter, W. Schulz-Schuffer, and et al. Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease Cell Physiol Biochem 20 2007 947 956
22. S. Liu, Y. Liu, W. Hao, L. Wolf, A.J. Kiliaan, B. Penke, C.E. Rube, J. Walter, M.T. Heneka, T. Hartmann, and et al. TLR2 is a primary receptor for Alzheimer's amyloid beta peptide to trigger neuroinflammatory activation J Immunol 188 2012 1098 1107
23. Y. Doi, T. Mizuno, Y. Maki, S. Jin, H. Mizoguchi, M. Ikeyama, M. Doi, M. Michikawa, H. Takeuchi, and A. Suzumura Microglia activated with the toll-like receptor 9 ligand CpG attenuate oligomeric amyloid {beta} neurotoxicity in in vitro and in vivo models of Alzheimer's disease Am J Pathol 175 2009 2121 2132
24. M. Yu, H. Wang, A. Ding, D.T. Golenbock, E. Latz, C.J. Czura, M.J. Fenton, K.J. Tracey, and H. Yang HMGB1 signals through toll-like receptor (TLR) 4 and TLR2 Shock 26 2006 174 179
25. J. Tian, A.M. Avalos, S.Y. Mao, B. Chen, K. Senthil, H. Wu, P. Parroche, S. Drabic, D. Golenbock, C. Sirois, and et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE Nat Immunol 8 2007 487 496
26. E. Okun, K.J. Griffioen, J.D. Lathia, S.C. Tang, M.P. Mattson, and T.V. Arumugam Toll-like receptors in neurodegeneration Brain Res Rev 59 2009 278 292
27. K.M. Lucin, and T. Wyss-Coray Immune activation in brain aging and neurodegeneration: too much or too little? Neuron 64 2009 110 122
28. F.Y. Liew, D. Xu, E.K. Brint, and L.A. O'Neill Negative regulation of toll-like receptor-mediated immune responses Nat Rev Immunol 5 2005 446 458
29. S. Levesque, T. Taetzsch, M.E. Lull, J.A. Johnson, C. McGraw, and M.L. Block The role of MAC1 in diesel exhaust particle-induced microglial activation and loss of dopaminergic neuron function J Neurochem 125 2013 756 765
30. J.K. Ryu, D. Davalos, and K. Akassoglou Fibrinogen signal transduction in the nervous system J Thromb Haemost 7 Suppl 1 2009 151 154
31. X. Hu, D. Zhang, H. Pang, W.M. Caudle, Y. Li, H. Gao, Y. Liu, L. Qian, B. Wilson, D.A. Di Monte, and et al. Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson's disease J Immunol 181 2008 7194 7204
32. S.I. Anderson, N.A. Hotchin, and G.B. Nash Role of the cytoskeleton in rapid activation of CD11b/CD18 function and its subsequent downregulation in neutrophils J Cell Sci 113 Pt 15 2000 2737 2745
33. N.P. Podolnikova, A.V. Podolnikov, T.A. Haas, V.K. Lishko, and T.P. Ugarova Ligand recognition specificity of leukocyte integrin alphaMbeta2 (Mac-1, CD11b/CD18) and its functional consequences Biochemistry 54 2015 1408 1420
34. H. Akiyama, and P.L. McGeer Brain microglia constitutively express beta-2 integrins J Neuroimmunol 30 1990 81 93
35. G.T. Liberatore, V. Jackson-Lewis, S. Vukosavic, A.S. Mandir, M. Vila, W.G. McAuliffe, V.L. Dawson, T.M. Dawson, and S. Przedborski Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease Nat Med 5 1999 1403 1409
36. S. Wang, C.H. Chu, T. Stewart, C. Ginghina, Y. Wang, H. Nie, M. Guo, B. Wilson, J.S. Hong, and J. Zhang α-Synuclein, a chemoattractant, directs microglial migration via H2O2-dependent Lyn phosphorylation Proc Natl Acad Sci U S A 112 2015 E1926 E1935
37. S. Rotshenker Microglia and macrophage activation and the regulation of complement-receptor-3 (CR3/MAC-1)-mediated myelin phagocytosis in injury and disease J Mol Neurosci 21 2003 65 72
38. Z. Pei, H. Pang, L. Qian, S. Yang, T. Wang, W. Zhang, X. Wu, S. Dallas, B. Wilson, J.M. Reece, and et al. MAC1 mediates LPS-induced production of superoxide by microglia: the role of pattern recognition receptors in dopaminergic neurotoxicity Glia 55 2007 1362 1373
39. K. Bedard, and K.H. Krause The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology Physiol Rev 87 2007 245 313
40. Z. Nayernia, V. Jaquet, and K.H. Krause New insights on NOX enzymes in the central nervous system Antioxid Redox Signal 20 2014 2815 2837
41. L. Qin, Y. Liu, and J.S.F.T.C. Hong NADPH oxidase and aging drive microglial activation, oxidative stress and dopaminergic neurodegeneration following systemic LPS administration Glia 61 2013 855 868
42. Q. Wang, L. Qian, S.H. Chen, C.H. Chu, B. Wilson, E. Oyarzabal, S. Ali, B. Robinson, D. Rao, and J.S. Hong Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson's disease models Brain 138 2015 1247 1262
43. L. Qian, X. Gao, Z. Pei, X. Wu, M. Block, B. Wilson, J.S. Hong, and P.M. Flood NADPH oxidase inhibitor DPI is neuroprotective at femtomolar concentrations through inhibition of microglia over-activation Parkinsonism Relat Disord 13 Suppl 3 2007 S316 S320
44. A. Simonyi, P. Serfozo, T.M. Lehmidi, J. Cui, Z. Gu, D.B. Lubahn, A.Y. Sun, and G.Y. Sun The neuroprotective effects of apocynin Front Biosci (Elite Ed) 4 2012 2183 2193
45. A. Federico, E. Cardaioli, P. Da Pozzo, P. Formichi, G.N. Gallus, and E. Radi Mitochondria, oxidative stress and neurodegeneration J Neurol Sci 322 2012 254 262
46. H.M. Gao, H. Zhou, and J.S. Hong NADPH oxidases: novel therapeutic targets for neurodegenerative diseases Trends Pharmacological Sci 33 2012 295 303
47. P.P. Zandi, J.C. Anthony, A.S. Khachaturian, S.V. Stone, D. Gustafson, J.T. Tschanz, M.C. Norton, K.A. Welsh-Bohmer, and J.C. Breitner Cache County Study G: Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study Arch Neurol 61 2004 82 88
48. M.C. Morris, D.A. Evans, J.L. Bienias, C.C. Tangney, D.A. Bennett, N. Aggarwal, R.S. Wilson, and P.A. Scherr Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study JAMA 287 2002 3230 3237
49. Parkinson Study Group QEI, M.F. Beal, D. Oakes, I. Shoulson, C. Henchcliffe, W.R. Galpern, R. Haas, J.L. Juncos, J.G. Nutt, T.S. Voss, and et al. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit JAMA Neurol 71 2014 543 552
50. Y.C. Shen, W.F. Chiou, Y.C. Chou, and C.F. Chen Mechanisms in mediating the anti-inflammatory effects of baicalin and baicalein in human leukocytes Eur J Pharmacol 465 2003 171 181
51. J.M. Bator, M. Weitzberg, and R.M. Burch N-[9H-(2,7-dimethylfluorenyl-9-methoxy)carbonyl]-L-leucine, NPC 15669, prevents neutrophil adherence to endothelium and inhibits CD11b/CD18 upregulation Immunopharmacology 23 1992 139 149
52. Y. Liu, L. Qin, G. Li, W. Zhang, L. An, B. Liu, and J.S. Hong Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation J Pharm Exp Ther 305 2003 212 218
53. L. Qian, Z. Xu, W. Zhang, B. Wilson, J.S. Hong, and P.M. Flood Sinomenine, a natural dextrorotatory morphinan analog, is anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase J Neuroinflammation 4 2007 23
54. B. Liu, L. Du, and J.S. Hong Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation J Pharm Exp Ther 293 2000 607 617
55. S.M. Crain, and K.F. Shen Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment Proc Natl Acad Sci U S A 92 1995 10540 10544
56. Q. Wang, E.J. Shin, X.K. Nguyen, Q. Li, J.H. Bach, G. Bing, W.K. Kim, H.C. Kim, and J.S. Hong Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in mice J Neuroinflammation 9 2012 124
57. L. Qin, Y. Liu, X. Qian, J.S. Hong, and M.L. Block Microglial NADPH oxidase mediates leucine enkephalin dopaminergic neuroprotection Ann N Y Acad Sci 1053 2005 107 120
58. L. Qian, H.M. Wu, S.H. Chen, D. Zhang, S.F. Ali, L. Peterson, B. Wilson, R.B. Lu, J.S. Hong, and P.M. Flood beta2-adrenergic receptor activation prevents rodent dopaminergic neurotoxicity by inhibiting microglia via a novel signaling pathway J Immunol 186 2011 4443 4454